TY - JOUR
T1 - Development, characterization and potential applications of a multicellular spheroidal human blood-brain barrier model integrating three conditionally immortalized cell lines
AU - Kitamura, Keita
AU - Umehara, Kenta
AU - Ito, Ryo
AU - Yamaura, Yoshiyuki
AU - Komori, Takafumi
AU - Morio, Hanae
AU - Akita, Hidetaka
AU - Furihata, Tomomi
N1 - Funding Information:
Acknowledgments This work was supported by Grants from JSPS KAKENHI (19K07214), AMED under Grant No. JP17be0304322h0001, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (Tokyo, Japan), Eisai (Tokyo, Japan), and Ono Pharmaceuticals (Osaka, Japan). Otherwise, we have no financial relationship to disclose for this manuscript.
Publisher Copyright:
© 2021 Pharmaceutical Society of Japan. All rights reserved.
PY - 2021/7
Y1 - 2021/7
N2 - In vitro blood-brain barrier (BBB) models are essential research tools for use in developing braintargeted drugs and understanding the physiological and pathophysiological functions of the BBB. To develop BBB models with better functionalities, three-dimensional (3D) culture methods have gained significant attention as a promising approach. In this study, we report on the development of a human conditionally immortalized cell-based multicellular spheroidal BBB (hiMCS-BBB) model. After being seeded into nonattachment culture wells, HASTR/ci35 (astrocytes) and HBPC/ci37 cells (brain pericytes) self-assemble to form a spheroid core that is then covered with an outer monolayer of HBMEC/ci18 cells (brain microvascular endothelial cells). The results of immunocytochemistry showed the protein expression of several cellular junction and BBB-enriched transporter genes in HBMEC/ci18 cells of the spheroid model. The permeability assays showed that the hiMCS-BBB model exhibited barrier functions against the penetration of dextran (5 and 70 kDa) and rhodamine123 (a P-glycoprotein substrate) into the core. On the other hand, facilitation of 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl]amino)-2-deoxyglucose (2-NBDG; a fluorescent glucose analog) uptake was observed in the hiMCS-BBB model. Furthermore, tumor necrosis factor-alpha treatment elicited an inflammatory response in HBMEC/ci18 cells, thereby suggesting that BBB inflammation can be recapitulated in the hiMCS-BBB model. To summarize, we have developed an hiMCS-BBB model that possesses fundamental BBB properties, which can be expected to provide a useful and highly accessible experimental platform for accelerating various BBB studies.
AB - In vitro blood-brain barrier (BBB) models are essential research tools for use in developing braintargeted drugs and understanding the physiological and pathophysiological functions of the BBB. To develop BBB models with better functionalities, three-dimensional (3D) culture methods have gained significant attention as a promising approach. In this study, we report on the development of a human conditionally immortalized cell-based multicellular spheroidal BBB (hiMCS-BBB) model. After being seeded into nonattachment culture wells, HASTR/ci35 (astrocytes) and HBPC/ci37 cells (brain pericytes) self-assemble to form a spheroid core that is then covered with an outer monolayer of HBMEC/ci18 cells (brain microvascular endothelial cells). The results of immunocytochemistry showed the protein expression of several cellular junction and BBB-enriched transporter genes in HBMEC/ci18 cells of the spheroid model. The permeability assays showed that the hiMCS-BBB model exhibited barrier functions against the penetration of dextran (5 and 70 kDa) and rhodamine123 (a P-glycoprotein substrate) into the core. On the other hand, facilitation of 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl]amino)-2-deoxyglucose (2-NBDG; a fluorescent glucose analog) uptake was observed in the hiMCS-BBB model. Furthermore, tumor necrosis factor-alpha treatment elicited an inflammatory response in HBMEC/ci18 cells, thereby suggesting that BBB inflammation can be recapitulated in the hiMCS-BBB model. To summarize, we have developed an hiMCS-BBB model that possesses fundamental BBB properties, which can be expected to provide a useful and highly accessible experimental platform for accelerating various BBB studies.
KW - Blood-brain barrier
KW - Central nervous system disease
KW - Drug development
KW - Immortalized cell
KW - In vitro model
KW - Spheroid
UR - http://www.scopus.com/inward/record.url?scp=85109100027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109100027&partnerID=8YFLogxK
U2 - 10.1248/bpb.b21-00218
DO - 10.1248/bpb.b21-00218
M3 - Article
C2 - 33896887
AN - SCOPUS:85109100027
SN - 0918-6158
VL - 44
SP - 984
EP - 991
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 7
ER -